Pharm Flashcards
What DA pathway controls movement?
Nigrastriatal
What DA pathway controls reward and perception?
Mesolimbic
What DA pathway controls executive function?
Mesocortical
What DA pathway controls pituitary prolaction function?
Tuberoinfundibular
2 Post-synaptic enzymes that terminate DA action:
MAO A or B
COMT
Hyperfunctioning Migrostriatal pathway causes:
Hypofunctioning causes:
Hyper: dyskinetic movemnt
Hypo: dyskinetic movement, parkinsonism
Hyperfunctioning Mesolimbic pathway causes:
Hypofunctioning causes:
Hyper: Addiction, hallucinations
Hypo: amotivation, apathy
Hyperfunctioning Mesocortical pathway causes:
Hypofunctioning causes:
Hyper: hypervigilance
Hypo: inattention
Hyperfunctioning Tuberoinfundibular pathway causes:
Hypofunctioning causes:
Hyper: hypoprolactinemia
Hypo: hyperprolactinemia
What drugs to enhance DA synthesis?
Levodopa: DA precursor
Carbidopa: combined therapy to prevent peripheral DA activity –> lower side effects
Results of low and high DA activity:
Low: distractable
High: hypervigilant
ADHD: ___ DA activity at ___
low, anterior cingulate
Parkinson: ___ DA activity at ___
low, striatum
Why is MTHFR enzyme important?
Genetics?
Creates L-methylfolate, which is the form that can cross BBB
TT alleles bad –> less DA made
Bupropion:
Treats?
Class?
Affects what pathway?
Antidepressant
NDRI
Mesocortical
Amphetamines mechanism:
- Block DAT
- Increase VMAT2 –>more DA release
Methylphenidate mechanism:
-Block DAT
2 wakefulness promoting stimulant drugs:
Treats?
Side effects?
- Modafinil, Armodafinil
- Narcolepsy
- Off label: ADHD
- P450-3A4 inducer
Selegiline:
low dose is used for for?
high dose is used for?
Low dose: MAO-B selective –> Parkinson
High dose: MAO A and B –> Depression
Rasagiline mechanism:
treats?
- MAO-B inhibitor
- Parkinson’s
MAOIs for Depression:
- Isocarboxazid
- Phenelzine
- Tranylcypromine
- Selegiline
Serotonin Syndrome
- MAOI decrease Serotonin breakdown
- Adding Serotonin drug –> toxic levels in CNS
- Tremor, muscle spasm, vital changes, hyperthermia, delirium, coma, death
COMTi drugs:
treats?
effect on neurotransmitters?
- Entacapone, Tolcapone
- Parkinson’s
- elevate DA and NE
D2 receptor agonists:
treats?
- Bromocriptine, pramipexole, ropinerole, Apomorphine injection
- Parkinson’s or Restless leg Syndrome
D3 receptor agonists:
treats?
- Aripiprazole
- Antipsychotic for Schizo
- Depression
Amantadine mechanism:
treats?
- Release DA, block DAT, stimulate D2
- Parkinson’s, Influenza
Reserpine treats:
HTN, Schizo psychosis, causes Depression
Tetrabenazine treats:
Huntington’s Chorea by lowering DA availability
D2 receptor antagonist affects which pathways?
treats?
classification?
ALL; they are non-selective
Schizophrenia
FGAs (high, low potency), SGAs
What causes EPS?
Symptoms?
- High Potency FGA
- Akathisia, Dystonia, Parkinsonism, Neuroleptic Malignant Syndrome
Symptoms of Neuroleptic Malignant Syndrome:
- Hyperthermia
- Muscle rigidity
- Vital sign instability
- Rhabdomyolysis
What is Tardive Dyskinesia
- Chronic D2 receptor antagonism
- Permanent movement disorder side effect
- Choreic or Athetotic movements
High vs Low Potency FGA drugs:
- Haloperidol
- Thioridazine
- Thiothixine
- Fluphenazine
- Chlorpromazine
High:
Haloperidol
Fluphenazine
Thiothixine
Low:
Chlorpromazine
Thioridazine
Blocking ___ receptor lowers EPS risk
Serotonin 2a (5HT2a)
Side effects of ‘Dones’ vs ‘Pines’
Dones: more EPS
Pines: more sedating, more metabolic syndrome
Clozapine risks and benefits
- Risk of agranulocytosis
- Most metabolic risk of any agent
- No neuromuscular effect –> no EPS/TD